Smith & Nephew (NYSE:SNN) Upgraded to Strong-Buy at StockNews.com

Smith & Nephew (NYSE:SNN) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Monday.

SNN has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Smith & Nephew in a report on Wednesday, July 24th. They issued a “buy” rating on the stock. UBS Group upgraded shares of Smith & Nephew from a “neutral” rating to a “buy” rating in a research note on Wednesday, June 5th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Smith & Nephew currently has an average rating of “Moderate Buy”.

Smith & Nephew Stock Down 3.3 %

Smith & Nephew stock traded down $1.02 during trading on Monday, hitting $29.44. The company had a trading volume of 822,686 shares, compared to its average volume of 943,426. Smith & Nephew has a 1-year low of $21.52 and a 1-year high of $31.13. The company’s 50 day simple moving average is $26.62 and its 200-day simple moving average is $26.40. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44.

Institutional Trading of Smith & Nephew

A number of hedge funds have recently added to or reduced their stakes in the business. International Assets Investment Management LLC acquired a new stake in Smith & Nephew during the fourth quarter worth about $716,000. Allworth Financial LP raised its stake in Smith & Nephew by 65.8% during the 4th quarter. Allworth Financial LP now owns 1,878 shares of the medical equipment provider’s stock valued at $51,000 after acquiring an additional 745 shares during the last quarter. Bleakley Financial Group LLC boosted its holdings in shares of Smith & Nephew by 26.0% in the fourth quarter. Bleakley Financial Group LLC now owns 11,865 shares of the medical equipment provider’s stock valued at $324,000 after acquiring an additional 2,451 shares in the last quarter. Simplicity Solutions LLC raised its position in Smith & Nephew by 26.0% in the fourth quarter. Simplicity Solutions LLC now owns 11,865 shares of the medical equipment provider’s stock worth $324,000 after acquiring an additional 2,451 shares in the last quarter. Finally, London & Capital Asset Management Ltd purchased a new stake in shares of Smith & Nephew during the 4th quarter worth approximately $1,054,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.